Sabby Management’s CervoMed CRVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$593K Sell
199,678
-49,202
-20% -$137K 6.58% 6
2026
Q2
$772K Buy
+248,880
New +$877K 0.7% 10
2020
Q1
– Sell
-14,473
Closed -$500K – 94
2019
Q4
$500K Buy
14,473
+8,235
+132% +$503K 0.14% 35
2019
Q3
$865K Sell
6,238
-10
-0.2% -$1.62K 0.47% 26
2019
Q2
$1.34M Buy
+6,248
New +$1.68M 1.68% 14

Other funds holding CRVO

Sabby Management's CRVO Position: Q3 2026 in Review

Sabby Management reduced its CervoMed (CRVO) stake by 20% in Q3 2026, selling an estimated $137K and leaving 199,678 shares worth $593K. The position accounts for 6.58% of the portfolio, ranked #6.

Sabby Management first reported a position in CRVO in Q2 2019 and has held it in 5 quarters since. The position peaked at $1.34M in Q2 2019. 36 funds tracked by Wall St. Rank hold CRVO as of Q3 2026.

  • Sabby Management held 199,678 shares of CervoMed worth $593K as of Q3 2026.
  • Sabby Management sold 49,202 CervoMed shares in Q3 2026, an estimated $137K.
  • CervoMed made up 6.58% of Sabby Management's portfolio in Q3 2026, its #6 holding.
  • Sabby Management first reported a position in CervoMed in Q2 2019 and has held it in 5 quarters since.
  • Sabby Management's CervoMed position peaked at $1.34M in Q2 2019.
  • 36 funds tracked by Wall St. Rank held CervoMed as of Q3 2026.

Based on Sabby Management's 13F filing for Q3 2026, filed 13 Nov 2026.